No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Asciminib is shown to be safe and efficacious in clinical practice for treating patients with chronic myeloid leukemia

byKathleen Lau

February 26, 2021

in StudyGraphics

Transdermal estrogen shows similar cardiovascular safety profile to traditional luteinizing hormone therapy in patients with prostate cancer

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Endocrinology

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

August 28, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

One-year of Herceptin preferable to two-year regimen

Endocrinology

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

August 28, 2025

Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria

Gastroenterology

Trastuzumab deruxtecan leads to longer overall survival than ramucirumab plus paclitaxel in HER2-positive gastric cancer

August 27, 2025

Adding daratumumab increases progression free survival in multiple myeloma

Idecabtagene vicleucel showed a response in pre-treated multiple myeloma

Parents often unaware of adolescents’ suicidal thoughts

Xanomeline-trospium treatment showed improvement in patients with schizophrenia

Simvastatin associated with slowed fibroid growth in mice

Relugolix combination therapy led to reduction in uterine fibroid symptoms

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Asciminib is shown to be safe and efficacious in clinical practice for treating patients with chronic myeloid leukemia

RELATED REPORTS

Transdermal estrogen shows similar cardiovascular safety profile to traditional luteinizing hormone therapy in patients with prostate cancer

Idecabtagene vicleucel showed a response in pre-treated multiple myeloma

RelatedReports

Recent Reports